Among the 14 patients with GPA-associated CDI in our cohort, 42.9% had positive myeloperoxidase (MPO-ANCA), 35.7% had positive proteinase 3 (PR3-ANCA), and 21.4% had negative serologies (Table S4). The gene discussed is MPO; the disease is clostridium difficile infection.